Company Monitoring Page for Alnylam

latest headlines for company on cafepharma

Alnylam, Medtronic RNAi drug-device combo wows with preclinical data
Fierce Drug Delivery
Fri, 12/30/11 - 11:36 am
Tags:
Alnylam, Medtronic, Device, RNAi
A Step Forward for RNA Interference
NY Times, NY
Mon, 11/21/11 - 01:02 pm
Tags:
Alnylam, RNA interference, RNAi
Biotech Takeovers Could Heat Up These Stocks
Seeking Alpha
Fri, 11/18/11 - 11:47 am
Tags:
M&A, Acorda, Alnylam, Adolor, Cubist, Chelsea Therapeutics, Catalyst, Human Genome Sciences
3 Cancer Immunotherapy Biotechs With Catalysts For 2012
Seeking Alpha
Thu, 11/17/11 - 09:03 am
Tags:
Alnylam, Dendreon, GSK, Medivation, ImmunoCellular, Novartis, cancer, NewLink Genetics
4 Biotech Stocks Predictive Analysts Expect To Underperform
Seeking Alpha
Mon, 11/14/11 - 05:25 pm
Tags:
Dendreon, Seattle Genetics, Sunesis, Alnylam
9 Biotech Stocks Trading At Steepest Discount To Target Price
Seeking Alpha
Sun, 10/30/11 - 12:40 pm
Tags:
Inhibitex, Affymax, Alnylam, Incyte, Ziopharm, Array Biopharma, Ariad Pharmaceuticals, Xoma, Complete Genomics
3 Biotech Takeover/LBO Targets With Bullish Short Trends
Seeking Alpha
Wed, 10/26/11 - 10:25 am
Tags:
M&A, Alnylam, Seattle Genetics, Exelixis
Next big drug against cholesterol takes shape
HealthNews
Sat, 08/27/11 - 01:35 pm
Tags:
Regeneron, Sanofi, hypercholesterolemia, PCSK9, Amgen, Merck, Alnylam, Bristol-Myers Squibb, REGN727
Alnylam narrows loss on lower costs
Bizjournals.com
Tue, 08/2/11 - 12:26 pm
Tags:
earnings, Alnylam
4 Biotech Companies Reporting Earnings Next Week With Recent Winning Streaks
Seeking Alpha
Sat, 07/30/11 - 09:46 am
Tags:
Ariad Pharmaceuticals, NPS Pharmaceuticals, Immunogen, Alnylam
9 Small Biotechs Near 52-Week Lows
Motley Fool
Sat, 07/23/11 - 03:11 pm
Tags:
MannKind, Alnylam, Theratechnologies, Metabolix, Cell Therapeutics, Novavax, AVI BioPharma, Allos, Vanda
10 Biotech Takeover/LBO Targets With Bullish Options Sentiment
Seeking Alpha
Thu, 07/21/11 - 12:21 pm
Tags:
M&A, Chelsea Therapeutics, Amgen, Human Genome Sciences, Acorda Therapeutics, Celgene, Dendreon, InterMune, Biomarin, Alnylam, Exelixis
Alnylam Presents Phase I Data for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers, at American Society of Clinical Oncology (ASCO) Meeting
Yahoo/BusinessWire
Sun, 06/5/11 - 10:04 am
Tags:
Alnylam, liver cancer, ALN-VSP, RNAi
7 Dirt-Cheap Takeover Targets in Biotech
Seeking Alpha
Fri, 06/3/11 - 10:44 am
Tags:
M&A, Acorda Therapeutics, Antares, Alnylam, BioSante, Catalyst, Inhibitex, Keryx
The Biggest Gift Biotechs Can Give to Investors
Motley Fool
Tue, 05/31/11 - 12:36 pm
Tags:
investors, biotech, Vertex Pharmaceuticals, Exelixis, CytRx, GSK, Novavax, JNJ, Pfizer, Biogen Idec, Seattle Genetics, Immunogen, Alnylam
Battered but Unbroken Biotechs
Seeking Alpha
Tue, 03/1/11 - 10:26 am
Tags:
Amylin, Alnylam, Celldex, Exelixis, Human Genome Sciences, Isis Pharmaceuticals, Lexicon Pharmaceuticals, Neurocrine, Nektar, ONYX Pharmaceuticals, Ziopharm, Seattle Genetics
Time to Buy Into Stem Cells?
Motley Fool
Tue, 02/1/11 - 08:23 am
Tags:
stem cells, Geron, Neuralstem, StemCells, Pfizer, GSK, Cephalon, Mesoblast, Merck, Alnylam
Deals to Be Done After AstraZeneca Setback
WSJ Online
Thu, 12/23/10 - 08:26 am
Tags:
AstraZeneca, RSV, Cubist Pharmaceuticals, NanoBio, MicroDose Therapeutx, Novavax, Synagis, motavizumab, Alnylam
Alnylam says it won Europe RNA patent dispute
Yahoo/AP
Fri, 12/3/10 - 06:44 am
Tags:
patents, Alnylam, RNA, gene silencing, Merck, Pfizer, Sima
RNAi Is On Sale
Motley Fool
Tue, 11/30/10 - 10:52 am
Tags:
RNAi, Merck, Alnylam, Pfizer, Amgen, Novartis, Eli Lilly, Roche

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.